Literature DB >> 14532724

[A case of pheochromocytoma with hyperamylasemia].

So Yang Kim1, Ji Hoon Kim, Chang Hwan Kim, Soon Woo Nam, Youn Jung Kim, Jin Il Kim, Soo Heon Park, Joon Yeoll Han, Jae Kwang Kim, Kyu Won Chung, Hee Sik Sun.   

Abstract

Pheochromocytoma, a catecholamine-producing tumor of the chromaffin tissue, may present with various features. Herein, we report case of 66-year-old woman with pheochromocytoma accompanying hyperamylasemia and acute abdomen. She was admitted to another hospital due to myocardial infarction 5 months ago. At that time, pheochromocytoma was suggested on the basis of hormonal studies, but she refused surgical resection. When she came to our hospital, serum amylase level was 703 U/L. Subsequent studies revealed pancreatic type isoenzyme, and elevated lipase level. After normalization of serum amylase level, she undertook laparoscopic adrenalectomy. On pathologic examination, pheochromocytoma was confirmed. There are several cases of pheochromocytoma with hyperamylasemia. In general, the source of hyperamylasemia was thought to be pulmonary endothelial cells under ischemic damage caused by potent vasoconstrictive action of circulating catecholamines. In our case, analysis of isoenzymes and serum lipase level suggest that hyperamylasemia can originate from the pancreas. Thus, pancreatitis also should be considered when serum amylase level is elevated in pheochromocytoma.

Entities:  

Mesh:

Year:  2003        PMID: 14532724

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  2 in total

1.  Amylase: sensitive tumor marker for amylase-producing lung adenocarcinoma.

Authors:  Jie Zhang; Lixia Zhang; Shiyang Pan; Bing Gu; Yuping Zhen; Jiabin Yan; Yiqin Zhou
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  A case of a composite adrenal medullary tumor of pheochromocytoma and ganglioneuroma masquerading as acute pancreatitis.

Authors:  Eun-Kyoung Choi; Wan-Ho Kim; Keun-Yong Park
Journal:  Korean J Intern Med       Date:  2006-06       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.